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Abstract  
Background: Obstructive sleep apnoea (OSA) syndrome is a common disorder in the community. Association between hypertension and sleep 
apnoea and /or snoring has been described. The Berlin questionnaire is a validated instrument that is used to identify individuals who are at risk 
for OSA. The study aim to describe the prevalence of snoring and OSA among hypertensive subjects in South Western, Nigeria. Methods: This 
was a descriptive study conducted at the Cardiology clinic of Ladoke Akintola University of Technology LAUTECH Teaching Hospital, Osogbo, South 
West Nigeria. One hundred consecutive hypertensive patients were recruited from the clinic. The Berlin questionnaire and the Epworth sleepiness 
scale (ESS) were used to determine excessive daytime sleepiness and the risk of having OSA. Statistical analysis was done using SPSS 16.0. Data 
were summarized as means ± S.D and percentages. Results: The study participants consisted of 40 males (40.0%). The demographic data were 
similar between both genders except that females had higher mean body mass index than males. The prevalence of snoring was 50.0%. 52% 
were categorized as being at high risk of having OSA. Snorers were more likely to be older, males and to have a higher fasting blood sugar than 
non-snorers.96% of snorers reported excessive daytime somnolence as predicted by the ESS score compared to 4% of non snorers. Prevalence of 
snoring was also higher among overweight and obese hypertensive subjects than normal body mass index hypertensive subjects. Conclusion: 
Snoring is common among hypertensive subjects in South Western Nigeria. Clinically suspected OSA was similarly high in prevalence among them. 
Early identification and management may reduce the cardiovascular risk of hypertensive subjects.  
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Background 
 
Obstructive  sleep  apnoea  syndrome  (OSAS)  is  a  common  disorder  in  the  community  [1].  Association  between  hypertension  and  sleep 
apnoea/snoring has been described among many population [2,3]. The association between sleep related breathing disorders and cardiovascular 
disease is further stressed by reports of a high prevalence of sleep apnoea among patients with hypertension [3].  
  
Obstructive sleep apnoea syndrome is associated with increased morbidity and mortality. It is characterized by partial or complete collapse of the 
upper airways during sleep leading to impaired gas exchange and recurrent arousal from sleep. The consequences of OSAS include excessive 
daytime  sleepiness,  cognitive  dysfunction,  impaired  work  performance,  and  impairment  in  health-related  quality  of  life.  Observational  and 
experimental  evidence  suggests  that  obstructive  sleep  apnea  may  contribute  to  the  development  of  systemic  hypertension,  [4] 
cardiovasculardisease, [5] and abnormalities in glucose metabolism [6]. Obstructive sleep apnea is insidious and patients are often unaware of the 
associated symptoms. Cardinal manifestations include loud snoring, witnessed breathing pauses during sleep, fitful sleep quality, and excessive 
daytime sleepiness. Early recognition and appropriate therapy can ameliorate the neurobehavioral consequences and may also have favorable 
effects on cardiovascular health [7]. Habitual snoring is associated with hypertension, cerebrovascular disease and coronary heart disease [8,9]. 
The prevalence of snoring among adults varies from different part of the world from 5 to 44% [8,10,11]. In a report from Abuja, Nigeria , overall 
prevalence of snoring among adults was 31% while the prevalence of clinically Suspected Obstructive Sleep Apneas (CSOSA) was 1%, (1.9% in 
males, 0.5% in females) [11].  
  
There is dearth of information on the pattern of snoring and sleep apnoea among Nigerians with hypertension. The study aimed at describing the 
frequency of occurrence of snoring and risk of obstructive sleep apnoea among hypertensive subjects and their associated clinical correlates.  
  
  
Methods 
 
This was a cross sectional study. It was carried out at the Cardiology unit of the Ladoke Akintola University Teaching Hospital, Osogbo. Osun State 
Nigeria. One hundred patients being managed for hypertension were recruited consecutively for this study. Hypertension was diagnosed by either 
a  persistent  blood  pressure  >140/90mmHg  or  the  use  of  antihypertensive  medications.  Demographic  variables  such  as  age,  body  weight  in 
kilograms, height in meters, waist circumference hip circumference and gender of each participant were documented. Informed consent was taken 
from each participant. Ethical approval was obtained from the Institutional Ethical Review Board.  
  
The Epworth Sleepiness Scale (ESS) was used to determine excessive day time sleepiness. It is an eight item self administered questionnaire. 
Possible score ranges were from 0 to 24. For this study, an ESS score of more than 11 was taken to mean Excessive day time sleepiness EDS. The 
Berlin Questionnaire was used to identify the risk of having clinical obstructive sleep apnoea. The questionnaire consists of 3 categories related to 
the risk of having sleep apnea. Patients can be classified into High Risk or Low Risk based on their responses to the individual items and their 
overall scores in the symptom categories. Subjects were categorized as high risk for having OSA if there were 2 or more Categories where the 
score was positive and low risk if there was only 1 or no Categories where the score was positive [12]. The Berlin questionnaire has been 
documented  to  be  clinically  sensitive  and  correlates  significantly  with  the  presence  of  OSA  among  various  populations.  Clinically  Suspected 
Obstructive Sleep Apneas (CSOSA) was defined in accordance with the 2001 International Classification of Sleep Disorders [13].  
  
Statistical analysis was done using the Statistical Package for Social Sciences SPSS 16.0 (Chicago Ill.) Numerical data were summarized using 
means and standard deviation while categorical data were summarized using frequencies and percentages. Comparism between groups was done 
using t-test and Chi square.  
  
  
Results 
 
One hundred consecutive hypertensive subjects were recruited for the study. It consisted of 40 males (40.0%) and 60 females (60.0%). The age 
range was between 39 and 90 years. The mean age was 58.4±11.9 years. There was no significant difference between the mean age of males 
compared to female participants (57.1±10.8 vs. 59.2±12.6 years, p>0.05 respectively). Similarly systolic blood pressure, diastolic blood pressure, 
fasting blood sugar and waist-hip-ratio were similar between male and female participants (Table 1). The mean body mass index was significantly 
higher among females than male hypertensives (28.3±5.5 vs. 24.0±3.9, p<0.05 respectively). The proportion of those with abnormal Epworth 
sleepiness scale was similar between the male and the female participants. Snoring was commoner among male hypertensive subjects than female 
hypertensive subjects (55.0% vs. 46.7%, p<0.05 respectively). 96% of snorers reported excessive daytime somnolence as predicted by the ESS 
score compared to 4% of non snorers.  
  
Table 2 shows the demographic parameters between hypertensive subjects with reported history of snoring and non-snorers. The mean age of 
snorers was significantly higher than non-snorers (59.4±12.1vs. 56.1±11.9, p< 0.05 respectively). Likewise, systolic blood pressure and fasting 
blood sugar were significantly higher among snorers than non snorers (141.9±21.2, 5.90±1.0 vs. 134.9±14.1, 4.9±1.8, p<0.05 respectively). 
Mean Epworth sleepiness scale was significantly higher among snorers than non-snorers (8.74±3.9 vs. 7.1±4.7, p<0.05 respectively) reflecting an 
increased daytime somnolence among snorers. Almost all snorers were found to have a high risk of OSA using the Berlin score compared to only 
4% of non snorers.  
  
The prevalence of snoring based on age group is shown in Table 3. The highest prevalence of snoring was found in the sixth decade followed by 
those more than 70 years. Snoring was also found to be commoner among overweight and obese hypertensive subjects as shown in Table 3.  
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Discussion 
 
The study revealed that the prevalence of snoring among hypertensive Nigerians in this study was 50%. It also revealed that almost all the 
hypertensive snorers reported excessive daytime somnolence as predicted using the Epworth sleepiness scale. Male hypertensive subjects had a 
significantly higher frequency of snoring than their female counterparts. In men the frequency of snoring was 55% while it was 46.7% among 
female participants in the study. This is similar to what has been reported among other hypertensive population [14]. The prevalence of snoring 
among  these  hypertensive  subjects  was  however  greater  than  that  reported  among  non-hypertensive  Nigerians  [11].  Also,  about  52%  of 
hypertensive subjects were found to be at high risk for having obstructive sleep apnoea in this study. Hypertension is a well documented risk for 
developing sleep related difficulties such as sleep apnoea, hypopnoea and snoring [2,3,5,7].  
  
Individuals  with  OSA  have  been  shown  to  have  heightened  sympathetic  activity  due  to  activation  of  chemoreceptors  leading  to  peripheral 
vasoconstriction [15]. OSA also results in the production of important neurohumoral mediators of cardiac and vascular disease [16]. Individuals 
with OSA have increased production of the potent vasoconstrictor endothelin and impaired endothelial function, which affect vasomotion. OSA has 
also been associated with systemic inflammation, reflected by increases in C-reactive protein and serum amyloid A levels, which may advance 
atherosclerosis  and  is  associated  with  increased  cardiovascular  risk.  Perhaps  through  its  effects  on  sympathetic  activity  or  because  of  sleep 
deprivation, OSA may increase insulin resistance, which promotes cardiovascular risk via multiple pathways [17]. Also, OSA is associated with 
increased levels of leptin, a hormone secreted by fat cells that is also associated with cardiovascular events.  
  
This study also revealed that hypertensive subjects with positive history of snoring were significantly older than those without history of snoring. 
Furthermore, body mass index and fasting blood sugar were significantly higher among hypertensive subjects with history of snoring than those 
without  it.  This  highlights  the  fact  that  hypertensive  subjects  with  OSA  likely  have  increased  cardiovascular  risk.  The  prevalence  of  snoring 
increased with increasing age group with the highest incidence among those in the sixth decade and the very elderly group (>70 years).This 
agrees with other studies have shown that obstructive sleep apnoea and snoring are directly related to age. With advancing age, sleep-related 
difficulties become increasingly common and often manifest as subjective complaints of difficulty falling asleep, reduced duration of night-time 
awakenings,  and  the  amount  of  night-time  sleep  obtained  [18,19].  Mechanisms  proposed  for  the  age-related  increase  inprevalence  include 
increased deposition of fat in the parapharyngeal area, lengthening of the softpalate, and changes in body structures surrounding the pharynx 
[20,21].  
  
Several epidemiologic studies have described the higher incidence of snoring and sleep apnoea among men compared to their female counterparts. 
Several explanation account for this: first, women may be less likely to report classical symptoms such as loud snoring, apnoea, nocturnal sorting 
or gasping [22,23]. Secondly, differential response of the bed partner to the symptoms of obstructive breathing during sleep may also contribute 
to the clinical underrecognition of the disorder in women.  
  
This study shows that hypertensive who were overweight or obese were more likely to be having sleep related disorders including snoring than 
those with normal body mass index. Similarly, a higher percentage of overweight and obese subjects were found to be at a high risk of obstructive 
sleep apnoea using the Berlin questionnaire. Epidemiologic studies from around the world have consistently shown body weight as the strongest 
risk factor for obstructive sleep apnea. In the Wisconsin Sleep Cohort study, a one standard deviation difference in body mass index (BMI) was 
associated with a 4-fold increase in disease prevalence [24]. Other population- and community-based studies conducted in the United States and 
other countries have confirmed that excess body weight is uniformly associated with a graded increase in prevalence of obstructive sleep apnea 
[25-27].  
  
  
Conclusion 
 
This study therefore shows that snoring is a commonly prevalent associated condition among hypertensive subjects in Osogbo, Nigeria. Similarly 
many of them were found to be at a high risk of OSA. Snoring and clinically suspected OSA were associated with increasing age, body mass index, 
fasting blood sugar and systolic blood pressure. Hypertensive subjects with sleep related disorders may therefore have increased cardiovascular 
risk compared to those without sleep related disorders. Therefore, early identification and management of sleep related disorders such as snoring 
and obstructive sleep apnoea can further reduce the cardiovascular risk of hypertensive Nigerian subjects.  
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Table 1: Clinical and demographic characteristics of study participants based on gender 
Variable  Males (40)  Females (60)  P 
Age (years)  57.1±10.8  59.2±12.6  0.378 
SBP(mmHg)  138.0±23.3  137.3±14.8  0.873 
DBP(mmHg)  82.0±14.8  83.2±10.5  0.661 
FBS(mmol/l)  5.5±1.3  5.2±1.7  0.539 
ESS  8.1±1.7  8.1±4.5  0.978 
BMI (kg/m2)  24.0±3.9  28.3±5.5  0.000* 
WHR  0.93±0.06  0.92±0.07  0.604 
Frequency of snoring  22(55.0%)  28(46.7%)  0.043* 
Proportion of high risk of OSA  21(52.5%)  31(51.7%)  0.783 
Proportion of abnormal ESS score  13(32.5%)  21(35.0%)  0.879 
Key to table: SBP: systolic blood pressure, DBP: diastolic blood pressure, FBS: fasting blood glucose, ESS: Epworth sleepiness score, 
BMI: body mass index, WHR: waist hip ratio, OSA: obstructive sleep apnoea. 
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Table 2: Clinical and demographic characteristics of snorers compared to non-snorers 
Variable  Snorers (50)  Non snorers (50)  P 
Age (years)  59.4±12.1  56.1±11.9  0.041* 
SBP(mmHg)  141.9±21.2  134.9±14.1  0.0369* 
DBP (mmHg)  82.2±13.4  83.4±10.7  0.778 
FBS(mmol/l)  5.90±1.0  4.9±1.8  0.021* 
ESS  8.74±3.9  7.1±4.7  0.0429* 
BMI (kg/m2)  27.6±5.8  25.6±5.2  0.184 
WHR  0.93±0.07  0.91±0.06  0.107 
Proportion with ESS high risk of OSA  48 (96.0%)  2(4.0%)  0.000** 
SBP: systolic blood pressure, DBP: diastolic blood pressure, FBS: fasting blood glucose, ESS: Epworth sleepiness score, BMI: body 
mass index, WHR: waist hip ratio, OSA: obstructive sleep apnoea; *P<0.05 
  
 
 
 
 
 
Table 3: Prevalence of snoring based on age group and body mass index among study participants 
Age groups (n)  High risk  of OSA  Snoring present 
<40 years (7)  2(28.6%)  2(28.6%) 
41-50 (22)  11(50.0%)  12(54.5%) 
51-60(34)  20(58.8%)  21(61.8%) 
61-70(21)  9(42.9%)  8(38.1%) 
>70(16)  10(62.5%)  9(56.3%) 
BMI group  High risk of OSA  Snoring present 
Normal BMI(46)  22(47.8%)  21(45.7%) 
Overweight(23)  14(60.9%)  14(60.9%) 
Obesity (31)  16(51.6%)  15(48.3%) 
OSA –obstructive sleep apnoea 
  
 
 